Doximity (DOCS) Set to Announce Earnings on Thursday

Doximity (NASDAQ:DOCS) is set to issue its quarterly earnings data after the market closes on Thursday, November 7th. Analysts expect the company to announce earnings of $0.26 per share for the quarter. Doximity has set its FY 2025 guidance at EPS and its Q2 2025 guidance at EPS.Parties that are interested in registering for the company’s conference call can do so using this link.

Doximity (NASDAQ:DOCS) last posted its quarterly earnings data on Thursday, August 8th. The company reported $0.22 EPS for the quarter, beating analysts’ consensus estimates of $0.16 by $0.06. The company had revenue of $126.68 million for the quarter, compared to analyst estimates of $119.88 million. Doximity had a net margin of 32.53% and a return on equity of 19.26%. On average, analysts expect Doximity to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Doximity Stock Performance

NASDAQ DOCS opened at $41.93 on Wednesday. The firm has a market cap of $7.78 billion, a PE ratio of 52.43, a P/E/G ratio of 5.09 and a beta of 1.30. Doximity has a one year low of $20.28 and a one year high of $44.88. The firm’s fifty day moving average is $40.77 and its two-hundred day moving average is $32.55.

Insider Buying and Selling at Doximity

In other Doximity news, CFO Anna Bryson sold 30,000 shares of the company’s stock in a transaction dated Friday, August 9th. The shares were sold at an average price of $35.00, for a total value of $1,050,000.00. Following the sale, the chief financial officer now owns 309,627 shares of the company’s stock, valued at $10,836,945. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 37.40% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on the stock. Needham & Company LLC upgraded shares of Doximity from a “hold” rating to a “buy” rating and set a $38.00 price target on the stock in a research note on Friday, August 9th. Barclays upgraded shares of Doximity from an “equal weight” rating to an “overweight” rating and boosted their price target for the stock from $35.00 to $52.00 in a research note on Tuesday, October 15th. Truist Financial reiterated a “hold” rating and set a $35.00 price target (up from $31.00) on shares of Doximity in a research note on Wednesday, August 14th. Wells Fargo & Company lowered shares of Doximity from an “equal weight” rating to an “underweight” rating and dropped their price target for the stock from $27.00 to $19.00 in a research note on Thursday, July 18th. Finally, Canaccord Genuity Group boosted their price target on shares of Doximity from $37.00 to $40.00 and gave the stock a “buy” rating in a research note on Tuesday, August 20th. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, Doximity currently has a consensus rating of “Hold” and a consensus price target of $36.42.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.